These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 15805272)
1. A novel telomere structure in a human alternative lengthening of telomeres cell line. Marciniak RA; Cavazos D; Montellano R; Chen Q; Guarente L; Johnson FB Cancer Res; 2005 Apr; 65(7):2730-7. PubMed ID: 15805272 [TBL] [Abstract][Full Text] [Related]
2. Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies. Fasching CL; Bower K; Reddel RR Cancer Res; 2005 Apr; 65(7):2722-9. PubMed ID: 15805271 [TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cells. Varley H; Pickett HA; Foxon JL; Reddel RR; Royle NJ Nat Genet; 2002 Mar; 30(3):301-5. PubMed ID: 11919561 [TBL] [Abstract][Full Text] [Related]
4. Telomere maintenance by recombination in human cells. Dunham MA; Neumann AA; Fasching CL; Reddel RR Nat Genet; 2000 Dec; 26(4):447-50. PubMed ID: 11101843 [TBL] [Abstract][Full Text] [Related]
5. DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA. Fasching CL; Neumann AA; Muntoni A; Yeager TR; Reddel RR Cancer Res; 2007 Aug; 67(15):7072-7. PubMed ID: 17652140 [TBL] [Abstract][Full Text] [Related]
6. Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Perrem K; Bryan TM; Englezou A; Hackl T; Moy EL; Reddel RR Oncogene; 1999 Jun; 18(22):3383-90. PubMed ID: 10362359 [TBL] [Abstract][Full Text] [Related]
7. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: effect of ectopic hTERT. Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; Mikulits W; Bergmeister H; Setinek U; Wieser M; Chin SF; Caldas C; Micksche M; Cerni C; Berger W Cancer Res; 2006 Apr; 66(7):3584-92. PubMed ID: 16585183 [TBL] [Abstract][Full Text] [Related]
8. Alternative lengthening of telomeres in mammalian cells. Henson JD; Neumann AA; Yeager TR; Reddel RR Oncogene; 2002 Jan; 21(4):598-610. PubMed ID: 11850785 [TBL] [Abstract][Full Text] [Related]
9. Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome. Jeyapalan JN; Varley H; Foxon JL; Pollock RE; Jeffreys AJ; Henson JD; Reddel RR; Royle NJ Hum Mol Genet; 2005 Jul; 14(13):1785-94. PubMed ID: 15888482 [TBL] [Abstract][Full Text] [Related]
10. Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Ulaner GA; Hoffman AR; Otero J; Huang HY; Zhao Z; Mazumdar M; Gorlick R; Meyers P; Healey JH; Ladanyi M Genes Chromosomes Cancer; 2004 Oct; 41(2):155-62. PubMed ID: 15287028 [TBL] [Abstract][Full Text] [Related]
11. Telomere length maintenance--an ALTernative mechanism. Royle NJ; Foxon J; Jeyapalan JN; Mendez-Bermudez A; Novo CL; Williams J; Cotton VE Cytogenet Genome Res; 2008; 122(3-4):281-91. PubMed ID: 19188697 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the alternative lengthening of telomeres pathway by subtelomeric sequences in Saccharomyces cerevisiae. Grandin N; Gallego ME; White CI; Charbonneau M DNA Repair (Amst); 2020 Dec; 96():102996. PubMed ID: 33126043 [TBL] [Abstract][Full Text] [Related]
13. The first molecular details of ALT in human tumor cells. Muntoni A; Reddel RR Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R191-6. PubMed ID: 16244317 [TBL] [Abstract][Full Text] [Related]
14. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R. Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888 [TBL] [Abstract][Full Text] [Related]
15. A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. Cerone MA; Autexier C; LondoƱo-Vallejo JA; Bacchetti S Oncogene; 2005 Nov; 24(53):7893-901. PubMed ID: 16116482 [TBL] [Abstract][Full Text] [Related]
16. A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Henson JD; Hannay JA; McCarthy SW; Royds JA; Yeager TR; Robinson RA; Wharton SB; Jellinek DA; Arbuckle SM; Yoo J; Robinson BG; Learoyd DL; Stalley PD; Bonar SF; Yu D; Pollock RE; Reddel RR Clin Cancer Res; 2005 Jan; 11(1):217-25. PubMed ID: 15671549 [TBL] [Abstract][Full Text] [Related]
17. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation. Sun B; Chen M; Hawks CL; Hornsby PJ Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of telomeres in human cancer. Vera E; Canela A; Fraga MF; Esteller M; Blasco MA Oncogene; 2008 Nov; 27(54):6817-33. PubMed ID: 18762811 [TBL] [Abstract][Full Text] [Related]
19. Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway. Grobelny JV; Kulp-McEliece M; Broccoli D Hum Mol Genet; 2001 Sep; 10(18):1953-61. PubMed ID: 11555632 [TBL] [Abstract][Full Text] [Related]
20. Alternative lengthening of telomeres (ALT) and chromatin: is there a connection? Nittis T; Guittat L; Stewart SA Biochimie; 2008 Jan; 90(1):5-12. PubMed ID: 17935854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]